⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GOSS News
Gossamer Bio, Inc. Common Stock
INVESTOR NOTICE: Gossamer Bio, Inc. (GOSS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action- Hagens Berman
prnewswire.com
GOSS
Rosen Law Firm Urges Gossamer Bio, Inc. (NASDAQ: GOSS) Stockholders to Contact the Firm for Information About Their Rights
businesswire.com
GOSS
Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
GOSS
DEADLINE ALERT for GOSS, NUAI, and MEDP: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
globenewswire.com
GOSS
NUAI
MEDP
Portnoy Law Firm Announces Class Action on Behalf of Gossamer Bio, Inc. Investors
globenewswire.com
GOSS
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: SueWallSt
prnewswire.com
GOSS
GOSS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
GOSS
Gossamer Bio, Inc. (GOSS) Faces Securities Class Action Amid 80% Drop On Phase 3 PROSERA Trial Failure– Hagens Berman
globenewswire.com
GOSS
Pomerantz LLP Highlights Legal Filing Against Gossamer Bio, Inc. – GOSS
accessnewswire.com
GOSS
GOSS Investor Alert: Gossamer Bio Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Overstated Trial Prospects: Levi & Korsinsky
prnewswire.com
GOSS